Human subjects research with prisoners: putting the ethical question in context
By Osagie K. Obasogie and Keramet A. Reiter,
Bioethics
| 12. 16. 2010
[Commentary]
We write in response to the conversation initiated in Volume 24.1 of Bioethics, which focused on the role of prisoners in biomedical and behavioral research. As interdisciplinary legal scholars who have researched the history, ethics, and current practices of prison research in the United States, we write to encourage further dialogue about the Institute of Medicine's (IOM) recommendations to reform current standards for prisoners' participation as human subjects. Specifically, we challenge three critical assumptions, which underlie several articles in the Bioethics special issue.
First, we challenge the idea that a risk-benefit assessment applied to prisoner participants in research is too restrictive.1 On the contrary, we argue that it is too permissive. The IOM's risk-benefit proposal – the most significant of its five main recommendations – is designed to relax current standards that categorically restrict prisoners' participation as human subjects to four narrow situations that directly benefit prisoners.2 Current policies were implemented in response to substantial abuses directly connected to prisoners' vulnerability and deplorable prison conditions; a 1976 Commission concluded that widespread research in prisons should not be...
Related Articles
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
By Natalie Obiko Pearson, Jessica Brice, Susan Berfield, Vernon Silver, Kanoko Matsuyama, Cindy Wang, Sinduja Rangarajan, Fani Nikiforaki, Bloomberg | 12.12.2024
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured.
The human egg is a precious resource, exchanged in markets open, gray or black. To tell its story, we follow...
By Michelle LePage, TorontoMet Today | 12.13.2024
As more people access fertility services in their journeys to becoming parents, Toronto Metropolitan University professor Katie Hammond says the Canadian fertility industry is in need of greater oversight.
A professor at the Lincoln Alexander School of Law, Hammond’s latest...